Trident Texofab Limited

BSE:540726 Stock Report

Market Cap: ₹1.1b

Trident Texofab Balance Sheet Health

Financial Health criteria checks 2/6

Trident Texofab has a total shareholder equity of ₹179.6M and total debt of ₹379.1M, which brings its debt-to-equity ratio to 211.1%. Its total assets and total liabilities are ₹861.6M and ₹682.0M respectively. Trident Texofab's EBIT is ₹48.1M making its interest coverage ratio 0.8. It has cash and short-term investments of ₹1.7M.

Key information

211.1%

Debt to equity ratio

₹379.15m

Debt

Interest coverage ratio0.8x
Cash₹1.66m
Equity₹179.57m
Total liabilities₹681.99m
Total assets₹861.56m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 540726's short term assets (₹583.7M) exceed its short term liabilities (₹440.5M).

Long Term Liabilities: 540726's short term assets (₹583.7M) exceed its long term liabilities (₹241.5M).


Debt to Equity History and Analysis

Debt Level: 540726's net debt to equity ratio (210.2%) is considered high.

Reducing Debt: 540726's debt to equity ratio has increased from 169.6% to 211.1% over the past 5 years.

Debt Coverage: 540726's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: 540726's interest payments on its debt are not well covered by EBIT (0.8x coverage).


Balance Sheet


Discover healthy companies